




Searching News Database: Millennium
HSMN NewsFeed - 31 Mar 2025
Orna Therapeutics Appoints Joseph Bolen, Ph.D., as Chief Executive Officer
Orna Therapeutics Appoints Joseph Bolen, Ph.D., as Chief Executive Officer
HSMN NewsFeed - 7 Dec 2021
Corbus Pharmaceuticals Appoints Rachael Brake, Ph.D., as Chief Scientific Officer
Corbus Pharmaceuticals Appoints Rachael Brake, Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 17 Aug 2021
Remix Therapeutics Names Peter Smith, PhD, as President and Chief Executive Officer
Remix Therapeutics Names Peter Smith, PhD, as President and Chief Executive Officer
HSMN NewsFeed - 27 Oct 2020
Caris Life Sciences Raises $310 Million in Growth Capital from a Broad Syndicate of Leading Investors
Caris Life Sciences Raises $310 Million in Growth Capital from a Broad Syndicate of Leading Investors
HSMN NewsFeed - 13 May 2020
Spirovant Sciences Appoints Roland Kolbeck, PhD, as Chief Scientific Officer
Spirovant Sciences Appoints Roland Kolbeck, PhD, as Chief Scientific Officer
HSMN NewsFeed - 6 Feb 2019
Proteostasis Therapeutics Appoints Emmanuel Dulac and Kim Drapkin to Board of Directors
Proteostasis Therapeutics Appoints Emmanuel Dulac and Kim Drapkin to Board of Directors
HSMN NewsFeed - 1 Oct 2018
Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio
Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio
HSMN NewsFeed - 3 Jul 2017
BIOTRONIK US Announces Pivotal Trial Results of the Pulsar-18 Stent with 4-French Delivery System
BIOTRONIK US Announces Pivotal Trial Results of the Pulsar-18 Stent with 4-French Delivery System
HSMN NewsFeed - 31 Mar 2017
Corindus Announces First Robotic-Assisted PCI Procedures Performed in Asia Using CorPath(R) GRX System
Corindus Announces First Robotic-Assisted PCI Procedures Performed in Asia Using CorPath(R) GRX System
HSMN NewsFeed - 27 Jul 2016
Biocept Appoints Timothy C. Kennedy as Chief Financial Officer and Senior Vice President of Operations
Biocept Appoints Timothy C. Kennedy as Chief Financial Officer and Senior Vice President of Operations
HSMN NewsFeed - 13 Jul 2016
Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer
Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer
HSMN NewsFeed - 8 Jan 2016
NewLink Genetics Corporation Appoints Brian Wiley as Chief Commercial Officer
NewLink Genetics Corporation Appoints Brian Wiley as Chief Commercial Officer
HSMN NewsFeed - 3 Nov 2015
Jounce Therapeutics Appoints Elizabeth Trehu, M.D., to Chief Medical Officer
Jounce Therapeutics Appoints Elizabeth Trehu, M.D., to Chief Medical Officer
HSMN NewsFeed - 21 Oct 2015
Unum Therapeutics Expands Leadership Team by Appointing Dr. Michael J. Vasconcelles as Chief Medical Officer
Unum Therapeutics Expands Leadership Team by Appointing Dr. Michael J. Vasconcelles as Chief Medical Officer
HSMN NewsFeed - 10 Sep 2015
Metamark Genetics Appoints Kenneth E. Weg as President and Chief Executive Officer
Metamark Genetics Appoints Kenneth E. Weg as President and Chief Executive Officer
HSMN NewsFeed - 29 Jul 2015
Unum Therapeutics Names Geoffrey Hodge as Senior Vice President, Operations
Unum Therapeutics Names Geoffrey Hodge as Senior Vice President, Operations
HSMN NewsFeed - 9 Jun 2015
Healthcare Executive Noel Mijares to Join Millennium Healthcare Inc. as New CEO
Healthcare Executive Noel Mijares to Join Millennium Healthcare Inc. as New CEO
HSMN NewsFeed - 21 May 2015
Jose-Carlos Gutiérrez-Ramos, Ph.D. Joins Synlogic as Chief Executive Officer
Jose-Carlos Gutiérrez-Ramos, Ph.D. Joins Synlogic as Chief Executive Officer
HSMN NewsFeed - 23 Apr 2015
Pain Therapeutics Announces Appointment of Senior Vice President, Regulatory Affairs
Pain Therapeutics Announces Appointment of Senior Vice President, Regulatory Affairs
HSMN NewsFeed - 22 Oct 2014
Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors
Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors
HSMN NewsFeed - 29 Apr 2014
CryoLife Receives FDA 510(k) Clearance for PerClot(R) Topical Hemostatic Powder in the U.S.
CryoLife Receives FDA 510(k) Clearance for PerClot(R) Topical Hemostatic Powder in the U.S.
HSMN NewsFeed - 29 Jan 2014
Progenics Pharmaceuticals Announces the Appointment of Karen Ferrante, M.D. to Its Board of Directors
Progenics Pharmaceuticals Announces the Appointment of Karen Ferrante, M.D. to Its Board of Directors
HSMN NewsFeed - 17 Dec 2013
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development
HSMN NewsFeed - 9 Dec 2013
FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab
FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab
HSMN NewsFeed - 5 Dec 2013
Cerner and Claritas Genomics Will Collaborate to Advance Personalized Medicine
Cerner and Claritas Genomics Will Collaborate to Advance Personalized Medicine
HSMN NewsFeed - 8 Oct 2013
Terumo Interventional Systems Launches The Detachable AZUR(R) CX Peripheral Coil System
Terumo Interventional Systems Launches The Detachable AZUR(R) CX Peripheral Coil System
HSMN NewsFeed - 31 Jul 2013
Astellas Appoints New Senior Vice President of Global Oncology Development
Astellas Appoints New Senior Vice President of Global Oncology Development
HSMN NewsFeed - 31 Jul 2013
Biotech Industry Veteran Joseph Bolen Joins Moderna Therapeutics to be President of Research and Development
Biotech Industry Veteran Joseph Bolen Joins Moderna Therapeutics to be President of Research and Development
HSMN NewsFeed - 5 Jun 2013
Cook Medical Receives Clearance for Evolution(R) Biliary Controlled-Release Uncovered Stent
Cook Medical Receives Clearance for Evolution(R) Biliary Controlled-Release Uncovered Stent
HSMN NewsFeed - 3 Jan 2013
NewLink Genetics Appoints Mr. Brian Wiley as Vice President of Business Development
NewLink Genetics Appoints Mr. Brian Wiley as Vice President of Business Development
HSMN NewsFeed - 24 Aug 2012
Sapheon Completes First Closing in Series B Preferred Offering; Dr. Aaron Berez Joins Board of Directors
Sapheon Completes First Closing in Series B Preferred Offering; Dr. Aaron Berez Joins Board of Directors
HSMN NewsFeed - 23 Apr 2012
Nephros Appoints John C. Houghton as President and Chief Executive Officer
Nephros Appoints John C. Houghton as President and Chief Executive Officer
HSMN NewsFeed - 27 Mar 2012
Constellation Pharmaceuticals Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer
Constellation Pharmaceuticals Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer
HSMN NewsFeed - 17 Oct 2011
Spinal Cord Injury Medical Leader Dr. Edward Wirth Joins InVivo Therapeutics as Chief Science Officer
Spinal Cord Injury Medical Leader Dr. Edward Wirth Joins InVivo Therapeutics as Chief Science Officer
HSMN NewsFeed - 14 Oct 2011
EMKinetics Announces Start of Pivotal Trial for the TranStim(TM) Transdermal Neuromodulation System
EMKinetics Announces Start of Pivotal Trial for the TranStim(TM) Transdermal Neuromodulation System
HSMN NewsFeed - 11 Oct 2011
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
HSMN NewsFeed - 22 Sep 2011
Eleven Biotherapeutics Appoints Abbie Celniker, Ph.D., Chief Executive Officer
Eleven Biotherapeutics Appoints Abbie Celniker, Ph.D., Chief Executive Officer
HSMN NewsFeed - 31 Aug 2011
Selecta Biosciences Appoints Takashi Kei Kishimoto, Ph.D., as Chief Scientific Officer
Selecta Biosciences Appoints Takashi Kei Kishimoto, Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 27 Jun 2011
SciFluor Life Sciences Appoints Life Sciences Executive Arthur Hiller as CEO
SciFluor Life Sciences Appoints Life Sciences Executive Arthur Hiller as CEO
HSMN NewsFeed - 17 Jun 2011
Seattle Genetics Announces Promotion of Eric Dobmeier to Chief Operating Officer
Seattle Genetics Announces Promotion of Eric Dobmeier to Chief Operating Officer
HSMN NewsFeed - 9 Mar 2011
2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery
2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery
HSMN NewsFeed - 1 Feb 2011
Constellation Pharmaceuticals Expands Leadership Team with Drug Development Industry Veterans
Constellation Pharmaceuticals Expands Leadership Team with Drug Development Industry Veterans
HSMN NewsFeed - 19 Jan 2011
James E. Shipley, M.D., Named Chief Medical Officer of Concert Pharmaceuticals
James E. Shipley, M.D., Named Chief Medical Officer of Concert Pharmaceuticals
HSMN NewsFeed - 5 Jan 2011
Biogen Idec Appoints Doug Williams to Head R&D, Steven Holtzman to Head Corporate Development
Biogen Idec Appoints Doug Williams to Head R&D, Steven Holtzman to Head Corporate Development
HSMN NewsFeed - 5 Jan 2011
Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
HSMN NewsFeed - 27 Sep 2010
OrSense Introduces Non-Invasive Hemoglobin System for Anemia Monitoring in Maternal Health
OrSense Introduces Non-Invasive Hemoglobin System for Anemia Monitoring in Maternal Health
HSMN NewsFeed - 23 Sep 2010
BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
HSMN NewsFeed - 10 Jun 2010
Medline Expands Surgical Suite Product Portfolio With Agreement to Distribute Proxy Biomedical Surgical Mesh
Medline Expands Surgical Suite Product Portfolio With Agreement to Distribute Proxy Biomedical Surgical Mesh
HSMN NewsFeed - 24 May 2010
Seattle Genetics Names Vice President, Sales and Announces Management Promotion
Seattle Genetics Names Vice President, Sales and Announces Management Promotion
HSMN NewsFeed - 15 Apr 2010
Exactech Approved to Begin Marketing Novation(R) Hip System in High Demand Asian Market
Exactech Approved to Begin Marketing Novation(R) Hip System in High Demand Asian Market
HSMN NewsFeed - 7 Jan 2010
Constellation Pharmaceuticals Appoints Kerry K. Reinertsen, Ph.D. as Company's Chief Business Officer
Constellation Pharmaceuticals Appoints Kerry K. Reinertsen, Ph.D. as Company's Chief Business Officer
HSMN NewsFeed - 13 Oct 2009
Seattle Genetics Names Head of Commercial and Announces Management Promotion
Seattle Genetics Names Head of Commercial and Announces Management Promotion
HSMN NewsFeed - 2 Sep 2009
FDA to Review Supplement Containing Long-Term Survival Data For VELCADE(R) (bortezomib) For Injection
FDA to Review Supplement Containing Long-Term Survival Data For VELCADE(R) (bortezomib) For Injection
HSMN NewsFeed - 9 Jul 2009
Facet Biotech Appoints Mark Rolfe, Ph.D. as Senior Vice President and Chief Scientific Officer
Facet Biotech Appoints Mark Rolfe, Ph.D. as Senior Vice President and Chief Scientific Officer
HSMN NewsFeed - 8 Jun 2009
Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
HSMN NewsFeed - 27 May 2009
Agios Pharmaceuticals Appoints David Schenkein, M.D. as CEO and Duncan Higgons as COO
Agios Pharmaceuticals Appoints David Schenkein, M.D. as CEO and Duncan Higgons as COO
HSMN NewsFeed - 13 May 2009
Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer
Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer
HSMN NewsFeed - 8 Apr 2009
Cerulean Pharma Inc. Announces Appointment of Oliver S. Fetzer as President and Chief Executive Officer
Cerulean Pharma Inc. Announces Appointment of Oliver S. Fetzer as President and Chief Executive Officer
HSMN NewsFeed - 2 Apr 2009
RXi Pharmaceuticals Announces an Addition, Promotions Among Senior Management Team
RXi Pharmaceuticals Announces an Addition, Promotions Among Senior Management Team
HSMN NewsFeed - 12 Mar 2009
Ipsen: AZZALURE Approved in the UK for Aesthetic Use in the Treatment of Glabellar Lines
Ipsen: AZZALURE Approved in the UK for Aesthetic Use in the Treatment of Glabellar Lines
HSMN NewsFeed - 26 Feb 2009
Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
HSMN NewsFeed - 9 Jan 2009
Integra LifeSciences Launches a Series of PEEK-Optima(R) Interbody Spinal Implants
Integra LifeSciences Launches a Series of PEEK-Optima(R) Interbody Spinal Implants
HSMN NewsFeed - 8 Jan 2009
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO
HSMN NewsFeed - 8 Dec 2008
Given Imaging Acquires Medtronic's Bravo(R) pH Monitoring Business for Diagnosing GERD
Given Imaging Acquires Medtronic's Bravo(R) pH Monitoring Business for Diagnosing GERD
HSMN NewsFeed - 4 Nov 2008
Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D
Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D
HSMN NewsFeed - 14 Oct 2008
Surface Logix Appoints Keith Dionne as President and Chief Executive Officer
Surface Logix Appoints Keith Dionne as President and Chief Executive Officer
HSMN NewsFeed - 14 Oct 2008
Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter
Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter
HSMN NewsFeed - 8 Sep 2008
VELCADE(R) (Black Triangle Drug) (bortezomib) Approved For Previously Untreated Multiple Myeloma
VELCADE(R) (Black Triangle Drug) (bortezomib) Approved For Previously Untreated Multiple Myeloma
HSMN NewsFeed - 4 Sep 2008
Microfabrica Secures $22.5 Million Funding to Grow Its Medical Device Business
Microfabrica Secures $22.5 Million Funding to Grow Its Medical Device Business
HSMN NewsFeed - 28 Jul 2008
EPIX Pharmaceuticals Announces Resignation of CEO; Names Elkan Gamzu Interim CEO
EPIX Pharmaceuticals Announces Resignation of CEO; Names Elkan Gamzu Interim CEO
HSMN NewsFeed - 17 Jul 2008
Cynosure Introduces Affirm CO2(TM) Workstation for Advanced Ablative Therapy
Cynosure Introduces Affirm CO2(TM) Workstation for Advanced Ablative Therapy
HSMN NewsFeed - 24 Jun 2008
Portola Pharmaceuticals Names William Lis Vice President of Business Development and Commercial Operations
Portola Pharmaceuticals Names William Lis Vice President of Business Development and Commercial Operations
HSMN NewsFeed - 29 Apr 2008
Takeda and Millennium Announce Early Termination of Hart-Scott-Rodino Waiting Period
Takeda and Millennium Announce Early Termination of Hart-Scott-Rodino Waiting Period
HSMN NewsFeed - 10 Apr 2008
Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
HSMN NewsFeed - 10 Apr 2008
Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
HSMN NewsFeed - 7 Apr 2008
KCI to Acquire LifeCell for $1.7 Billion in Cash Creating a Global Medical Technology Leader
KCI to Acquire LifeCell for $1.7 Billion in Cash Creating a Global Medical Technology Leader
HSMN NewsFeed - 4 Mar 2008
Momenta Pharmaceuticals Appoints Dr. James M. Roach as Chief Medical Officer
Momenta Pharmaceuticals Appoints Dr. James M. Roach as Chief Medical Officer
HSMN NewsFeed - 20 Feb 2008
Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkin's Lymphoma
Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkin's Lymphoma
HSMN NewsFeed - 31 Jan 2008
Cynosure Launches Three Aesthetic Products at American Academy of Dermatology 2008 Annual Meeting
Cynosure Launches Three Aesthetic Products at American Academy of Dermatology 2008 Annual Meeting
HSMN NewsFeed - 28 Jan 2008
Medtronic Announces Exclusive Licensing of Arbor Surgical Technologies Pericardial Heart Valve
Medtronic Announces Exclusive Licensing of Arbor Surgical Technologies Pericardial Heart Valve
HSMN NewsFeed - 15 Oct 2007
FDA Expands VELCADE(R) (Bortezomib) for Injection Label for Patients with Multiple Myeloma
FDA Expands VELCADE(R) (Bortezomib) for Injection Label for Patients with Multiple Myeloma
HSMN NewsFeed - 7 Sep 2007
Bausch & Lomb Launches the Stellaris(TM) Vision Enhancement System in Europe at ESCRS 2007
Bausch & Lomb Launches the Stellaris(TM) Vision Enhancement System in Europe at ESCRS 2007
HSMN NewsFeed - 21 Aug 2007
St. Jude Medical Announces Japanese Approval of the Angio-Seal STS Plus Vascular Closure Device
St. Jude Medical Announces Japanese Approval of the Angio-Seal STS Plus Vascular Closure Device
HSMN NewsFeed - 31 Jul 2007
Gene Logic Recruits Pharmaceutical Executive as Senior Vice President of Clinical Development
Gene Logic Recruits Pharmaceutical Executive as Senior Vice President of Clinical Development
HSMN NewsFeed - 21 May 2007
U.S. FDA Approves VELCADE(R) + DOXIL(R) Combination for Treatment of Relapsed/Refractory Multiple Myeloma
U.S. FDA Approves VELCADE(R) + DOXIL(R) Combination for Treatment of Relapsed/Refractory Multiple Myeloma
HSMN NewsFeed - 1 May 2007
Robert G. Pietrusko Joins ViroPharma as Vice President of Global Regulatory Affairs and Quality
Robert G. Pietrusko Joins ViroPharma as Vice President of Global Regulatory Affairs and Quality
HSMN NewsFeed - 19 Apr 2007
Merck KGaA and WHO Conclude Partnership to Control Schistosomiasis in Africa
Merck KGaA and WHO Conclude Partnership to Control Schistosomiasis in Africa
HSMN NewsFeed - 17 Apr 2007
Millennium Discovers Biomarkers Potentially Predictive of Response to VELCADE(R) (Bortezomib) for Injection
Millennium Discovers Biomarkers Potentially Predictive of Response to VELCADE(R) (Bortezomib) for Injection
HSMN NewsFeed - 12 Apr 2007
Synta Pharmaceuticals Corp. Strengthens Oncology Clinical and Commercial Team
Synta Pharmaceuticals Corp. Strengthens Oncology Clinical and Commercial Team
HSMN NewsFeed - 10 Apr 2007
Trellis Bioscience Names Bruce Keyt, Ph.D. as Chief Technology Officer and Vice President of Research
Trellis Bioscience Names Bruce Keyt, Ph.D. as Chief Technology Officer and Vice President of Research
HSMN NewsFeed - 29 Mar 2007
Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
HSMN NewsFeed - 20 Mar 2007
Vidacare(R) Announces Sales and Marketing Leader for New Hematology/Oncology Business Unit
Vidacare(R) Announces Sales and Marketing Leader for New Hematology/Oncology Business Unit
HSMN NewsFeed - 21 Feb 2007
St. Jude Medical Receives FDA Clearance for Venture Catheter with New Delivery Platform
St. Jude Medical Receives FDA Clearance for Venture Catheter with New Delivery Platform
HSMN NewsFeed - 13 Feb 2007
Millennium Dental Technologies Announces the Hiring of Tom Haney as VP of Business Development
Millennium Dental Technologies Announces the Hiring of Tom Haney as VP of Business Development
HSMN NewsFeed - 23 Jan 2007
Synta Pharmaceuticals Corp. Announces Additions to Senior Management Team
Synta Pharmaceuticals Corp. Announces Additions to Senior Management Team
HSMN NewsFeed - 9 Jan 2007
Cynosure Chosen as Provider of Fractional Anti-Aging Technology for American Laser Centers
Cynosure Chosen as Provider of Fractional Anti-Aging Technology for American Laser Centers
HSMN NewsFeed - 11 Dec 2006
VELCADE(R) (Bortezomib) for Injection Demonstrates Substantial Activity Across Range of Lymphomas
VELCADE(R) (Bortezomib) for Injection Demonstrates Substantial Activity Across Range of Lymphomas
HSMN NewsFeed - 11 Dec 2006
Multiple Myeloma Patients Respond to Retreatment with VELCADE(R) (Bortezomib) for Injection
Multiple Myeloma Patients Respond to Retreatment with VELCADE(R) (Bortezomib) for Injection
HSMN NewsFeed - 11 Dec 2006
CryoLife Receives FDA 510(k) Clearance for ProPatch(TM) Soft Tissue Repair Matrix
CryoLife Receives FDA 510(k) Clearance for ProPatch(TM) Soft Tissue Repair Matrix
HSMN NewsFeed - 8 Dec 2006
FDA Approves VELCADE(R) (Bortezomib) for Injection for Aggressive Form of Non-Hodgkin's Lymphoma
FDA Approves VELCADE(R) (Bortezomib) for Injection for Aggressive Form of Non-Hodgkin's Lymphoma
HSMN NewsFeed - 4 Dec 2006
Publications Feature VELCADE(R) (Bortezomib) for Injection Strength In Hematological Cancers
Publications Feature VELCADE(R) (Bortezomib) for Injection Strength In Hematological Cancers
HSMN NewsFeed - 28 Nov 2006
Millennium Initiates Phase II Trial to Evaluate MLN3897 in Rheumatoid Arthritis
Millennium Initiates Phase II Trial to Evaluate MLN3897 in Rheumatoid Arthritis
HSMN NewsFeed - 28 Nov 2006
Adnexus Therapeutics Appoints Bruce A. Silver, MD, FACP as Medical Director
Adnexus Therapeutics Appoints Bruce A. Silver, MD, FACP as Medical Director
HSMN NewsFeed - 15 Nov 2006
Bayhill Therapeutics Names Robert S. King Vice President of Manufacturing
Bayhill Therapeutics Names Robert S. King Vice President of Manufacturing
HSMN NewsFeed - 11 Nov 2006
Bausch & Lomb Showcases New Technologies at American Academy of Ophthalmology Annual Meeting
Bausch & Lomb Showcases New Technologies at American Academy of Ophthalmology Annual Meeting
HSMN NewsFeed - 26 Oct 2006
Millennium and Ortho Biotech Enter into U.S. Co-Promotion Agreement for VELCADE(R)(bortezomib) for Injection
Millennium and Ortho Biotech Enter into U.S. Co-Promotion Agreement for VELCADE(R)(bortezomib) for Injection
HSMN NewsFeed - 10 Oct 2006
Genzyme Announces Proposal to Increase Its Offer to Acquire AnorMED to $13.50 Per Share in Cash
Genzyme Announces Proposal to Increase Its Offer to Acquire AnorMED to $13.50 Per Share in Cash
HSMN NewsFeed - 3 Oct 2006
Archemix Strengthens Management With Appointment of James Gilbert, M.D., as Chief Medical Officer
Archemix Strengthens Management With Appointment of James Gilbert, M.D., as Chief Medical Officer
HSMN NewsFeed - 26 Sep 2006
Millennium Agrees to Acquire AnorMED, Adding Phase III Oncology Product with Planned Near Term Launch Date
Millennium Agrees to Acquire AnorMED, Adding Phase III Oncology Product with Planned Near Term Launch Date
HSMN NewsFeed - 12 Sep 2006
Conceptus Announces Partnerships Now in Place with All Major Hysteroscope Manufacturers
Conceptus Announces Partnerships Now in Place with All Major Hysteroscope Manufacturers
HSMN NewsFeed - 31 May 2006
Archemix Corp. Strengthens its Board of Directors Adding Alnylam President and CEO, John Maraganore, Ph.D.
Archemix Corp. Strengthens its Board of Directors Adding Alnylam President and CEO, John Maraganore, Ph.D.
HSMN NewsFeed - 25 May 2006
GE Healthcare Announces First Installation of the Discovery VCT, the World's First Volumetric PET/CT System
GE Healthcare Announces First Installation of the Discovery VCT, the World's First Volumetric PET/CT System
HSMN NewsFeed - 11 May 2006
Genentech Announces Vice President Appointments in Commercial Operations and Product Development
Genentech Announces Vice President Appointments in Commercial Operations and Product Development
HSMN NewsFeed - 4 May 2006
ImmunoGen, Inc. to Develop Commercial-Scale Manufacturing Process for Trastuzumab-DM1 for Genentech
ImmunoGen, Inc. to Develop Commercial-Scale Manufacturing Process for Trastuzumab-DM1 for Genentech
Additional items found! 242

Members Archive contains
242 additional stories matching:
Millennium
(Password required)
Millennium
(Password required)